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        Introduction 
  The lamin A protein plays an important role in the structure and 
function of the nucleus, and mutations in the lamin A gene cause 
a large number of different human diseases, including cardio-
myopathies, muscular dystrophies, and Hutchinson-Gilford 
Progeria Syndrome (  Broers et al., 2006  ;   Capell and Collins, 
2006  ;   Mattout et al., 2006  ;   Parnaik and Manju, 2006  ). Covalent 
attachment of small ubiquitin-like modifi  er (SUMO) proteins to 
lysine residues in target proteins, or sumoylation, is an impor-
tant regulator of protein functional properties (  Hay, 2005  ; 
  Bossis and Melchior, 2006  ;   Kerscher et al., 2006  ). SUMO pro-
teins are covalently attached to target lysine residues by the 
SUMO E2 enzyme ubc9, and these substrate lysines are typi-
cally found within the consensus sequence    KXE  (    represents 
hydrophobic amino acids;   Desterro et al., 1997  ;   Johnson and 
Blobel, 1997  ;   Rodriguez et al., 2001  ;   Sampson et al., 2001  ). 
Cells express three major SUMO paralogues, SUMO-1, SUMO-2, 
and SUMO-3, with SUMO-2 and -3 being much more similar to 
each other than to SUMO-1 (  Hay, 2005  ;   Kerscher et al., 2006  ; 
  Bossis and Melchior, 2006  ). 
  Using a yeast two-hybrid screen, a previous study identi-
fi  ed an interaction between lamin A and ubc9, the SUMO E2 
protein (  Zhong et al., 2005  ). Based on this interaction, we hy-
pothesized that the lamin A protein could be a target of su-
moylation. The purpose of the experiments in this present study 
was to determine whether lamin A is indeed sumoylated in cells 
and, if so, what role this modifi  cation plays in regulating the 
function of this lamin. 
  Results and discussion 
  First, we sought to test for sumoylation of endogenous lamin A 
by performing immunoprecipitation of HeLa cell extracts using 
lamin A antibodies, followed by Western using antibodies against 
SUMO-1 or SUMO-2/SUMO-3 (because of the similarity of 
SUMO-2 and -3, it is likely that both of these SUMO proteins 
are recognized by this antibody). The results suggest that lamin A 
is SUMO modifi  ed and that it is preferentially modifi  ed by 
SUMO-2 compared with SUMO-1 (  Fig. 1 A  ). The results in 
  Fig. 1 C   indicate that lamin A protein in extracts of mouse heart 
is also sumoylated and that, like lamin A that is present in HeLa 
cell extracts, SUMO-2 appears to be the predominant SUMO 
protein attached to this protein. 
  Analysis of the lamin A amino acid sequence revealed a 
match to the sumoylation consensus sequence    KXE  (MKEE) 
surrounding lysine 201 in the rod-containing domain of lamin A 
(  Fig. 2 A  , top). To test whether sumoylation of the lamin A is 
  L
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E203K mutant lamin A proteins exhibit decreased sumoylation 
compared with the wild-type lamin A protein. 
  Sumoylation plays an important role in regulating the 
functional properties of target proteins in cells (  Hay, 2005  ;   Bossis 
and Melchior, 2006  ;   Kerscher et al., 2006  ). The wild-type 
lamin A protein exhibits a characteristic pattern of localization 
at the nuclear periphery (  Broers et al., 2006  ;   Capell and Collins, 
2006  ;   Mattout et al., 2006  ;   Parnaik and Manju, 2006  ). We hy-
pothesized that sumoylation of lamin A at lysine 201 may be 
important for this localization pattern. To test this hypothesis, 
HeLa cells were transfected with the wild-type or K201R la-
min A GFP fusion expression plasmids and then examined by 
fl  uorescence microscopy. As shown in   Fig. 3 A  , the wild-type 
lamin A GFP fusion protein exhibits the typical pattern of rela-
tively continuous nuclear peripheral localization. However, the 
K201R lamin A GFP fusion protein shows an altered localization 
pattern, with the mutant protein appearing to concentrate into 
foci. These results suggest that sumoylation of lamin A is im-
portant for the normal pattern of subcellular localization of this 
protein. Analysis of the subcellular localization of GFP fusion 
constructs of the E203G or E203K mutant lamin A proteins 
by fl  uorescence microscopy reveals that both of these mutant 
proteins exhibit altered localization patterns similar to that of 
the K201R mutant lamin A, in which these proteins are concen-
trated in foci, in contrast to the more continuous appearance 
of the wild-type lamin A at the nuclear periphery (  Fig. 3 A  ). 
The pattern we observed for the E203G lamin A is similar to 
that observed by a previous study (  Lloyd et al., 2002  ). To our 
knowledge, the localization of the E203K lamin A has not 
previously been reported. The percentages of cells exhibiting 
abnormal localization of the wild-type and mutant GFP  –  lamin A 
proteins are shown in Table S1 (available at http://www.jcb.org/
cgi/content/full/jcb.200712124/DC1). 
 To  confi  rm the effects of altered localization of the cardio-
myopathy-associated E203G and E203K lamin A mutants in a 
more physiologically relevant cell type, we repeated the experi-
ments shown in   Fig. 3 A   in mouse embryonic cardiomyocytes. 
The results, shown in   Fig. 3 B  , indicate that the K201R, E203G, 
and E203K lamin A mutants all exhibit aberrant localization pat-
terns in the cardiomyocytes (compared with wild-type lamin A) 
that are similar to those observed in HeLa cells. Percentages of 
cells exhibiting abnormal localization of wild-type and mutant 
GFP  –  lamin A are shown in Table S1. 
occurring at lysine 201, HeLa cells were transfected with mam-
malian expression plasmids encoding GFP fusion constructs of 
wild-type lamin A and lamin A in which this lysine was changed 
to a nonsumoylatable arginine (K201R), along with expression 
constructs encoding HA-tagged SUMO-1 or -2. Extracts of the 
transfected cells were subjected to immunoprecipitation with 
anti-GFP antibodies followed by anti-HA Western blot. The re-
sults of this experiment, in agreement with the results obtained 
for endogenous lamin A, indicated that the wild-type lamin A 
protein is covalently modifi  ed by SUMO-2 but not as effi  ciently 
sumoylated by SUMO-1 (  Fig. 2 A  , bottom). The results also 
show that the modifi  cation by SUMO-2 is not observed for the 
K201R lamin A mutant protein, suggesting that lysine 201 is the 
site of SUMO-2 attachment in this protein. 
  The glutamic acid residue at the fourth position in the su-
moylation consensus sequence     KXE is known to be important 
for the effi  ciency of SUMO addition to the nearby lysine in this 
sequence (  Rodriguez et al., 2001  ;   Sampson et al., 2001  ). Rele-
vant to this, two different disease-associated mutations of the 
human lamin A gene have been identifi  ed that change the glu-
tamic acid at this position (E203) in the sumoylation consensus 
sequence of this protein to a different amino acid (  Fig. 2 B  , top; 
  Fatkin et al., 1999  ;   Jakobs et al., 2001  ). In one of these mutants, 
glutamic acid 203 is changed to glycine (E203G), whereas in 
the other, it is changed to lysine (E203K). Both the E203G and 
E203K mutations of lamin A are associated with familial dilated 
cardiomyopathy and conduction system disease (  Fatkin et al., 
1999  ;   Jakobs et al., 2001  ), but the underlying molecular mecha-
nism by which these mutations alter lamin A function is not 
known. Based on the results in the previous paragraph demon-
strating that sumoylation of the lamin A protein occurs at lysine 
201 and on previous results indicating the importance of glu-
tamic acid for sumoylation at the preceding lysine of the    KXE 
sumoylation consensus sequence ( Rodriguez et al., 2001 ;  Sampson 
et al., 2001  ), we hypothesized that the E203G and E203K muta-
tions could possibly mediate their deleterious effects by result-
ing in decreased sumoylation of the lamin A protein. To test the 
feasibility of this hypothesis, we performed a transfection immuno-
precipitation experiment similar to that shown in   Fig. 2 A  , ex-
cept that here the sumoylation of wild-type GFP  –  lamin A was 
compared with that of GFP  –  lamin A constructs containing the 
E203G or E203K mutations. The results of this experiment, 
shown in   Fig. 2 B   (bottom), indicate that both the E203G and 
  Figure 1.       Endogenous lamin A is sumoylated.   
(A) Extracts of HeLa cells were subjected to 
immunoprecipitation using anti  –  lamin A anti-
bodies followed by Western blot assays using 
antibodies against SUMO-2, SUMO-1, or la-
min A (different from those used for immuno-
precipitation). (B) Western blot assays of HeLa 
cell lysates used for the immunoprecipitations 
using anti  –  SUMO-2 or   –  SUMO-1 antibodies. 
(C) Extracts prepared from mouse heart were 
subjected to immunoprecipitation using anti  –
  lamin A antibodies followed by Western blot 
assays using antibodies against SUMO-2, 
SUMO-1, or lamin A (different from those used 
for immunoprecipitation).     37 SUMOYLATION OF LAMIN A   • Zhang and Sarge 
glutamine. Transfection of HeLa cells was performed using Effectene trans-
fection reagent (QIAGEN), according to the manufacturer  ’  s protocol. Immuno-
precipitation analysis and ﬂ  uorescence microscopy were performed 48 h 
after the transfection. The GFP  –  lamin A plasmid was constructed from the 
pcDNA3.1-LMNA plasmid (gift of N. Zhong and W.T. Brown, Institute for 
Basic Research in Developmental Disabilities, Staten Island, NY). The coding 
  In light of the defective sumoylation and aberrant localiza-
tion patterns of the K201R, E203G, and E203K lamin A mutant 
proteins, we hypothesized that expression of these lamin A mu-
tant proteins could result in decreased cell viability. The results 
shown in   Fig. 3 C   indicate that this appears to be the case, as all 
three of these mutant lamin A proteins are associated with in-
creased cell death. 
  In the fi  nal set of experiments, we examined skin fi  bro-
blasts obtained from a patient that is heterozygous for the E203K 
lamin A mutation, which, as already described, is associated 
with cardiomyopathy (  Jakobs et al., 2001  ). Immunoprecipita-
tion of lamin A from these cells followed by SUMO-2 Western 
blot indicates that, as expected, levels of sumoylation of lamin A 
are reduced in cells from this individual compared with cells of 
a normal individual (  Fig. 4 A  ). This individual is heterozygous 
for the E203K lamin A mutation, thus we expect that lamin A 
sumoylation was decreased but not eliminated. Further, immuno-
fl  uorescence analysis of lamin A indicated more cells showing 
abnormal lamin A localization and nuclear morphology for the 
E203K fi  broblasts compared with normal fi  broblasts (  Fig. 4 B  ). 
The percentages of normal and E203K fi  broblasts exhibiting 
abnormal lamin A localization/nuclear morphology are shown 
in Table S1. The E203K fi  broblasts also exhibit increased cell 
death compared with the control fi  broblasts (  Fig. 4 C  ). 
  The results presented in this paper indicate that lysine 201 
of lamin A is a target of covalent modifi  cation by the SUMO-2 
protein and that this sumoylation is important for the normal 
pattern of subcellular localization of the lamin A protein. The re-
sults of these experiments also show that lamin A sumoylation is 
decreased in transfected mutant E203G and E203K lamin A pro-
teins that cause familial dilated cardiomyopathies and in lamin A 
of fi  broblasts of individuals with the E203K mutation. To our 
knowledge these are the fi  rst examples of human disease-causing 
mutations occurring in a crucial residue of a sumoylation con-
sensus sequence and resulting in decreased sumoylation of the 
mutant protein. 
  The results also indicate that the mutant E203G and E203K 
lamin A proteins exhibit altered subcellular localization patterns 
that are very similar to that of the SUMO attachment site mutant 
K201R lamin A protein. These results suggest a role for su-
moylation in the correct localization of lamin A in the cell. Fur-
ther, cells transfected with the E203G and E203K lamin A 
proteins and skin fi  broblasts of individuals with the E203K muta-
tion exhibit higher levels of cell death compared with cells trans-
fected with wild-type lamin A or normal skin fi  broblasts, 
respectively. Together, these results suggest that sumoylation is 
important for normal lamin A function and support a role for al-
tered sumoylation in the underlying molecular mechanism of 
familial dilated cardiomyopathies associated with the E203G/
E203K lamin A mutations. 
  Materials and methods 
  Cell culture and plasmids 
  HeLa cells were cultured in DME medium (Mediatech, Inc.) supplemented 
with 10% FBS and 100  ×   antibiotic-antimycotic (Invitrogen) in 5% CO  2  . 
Human skin ﬁ  broblasts (provided by R. Hershberger, University of Miami, 
Miami, FL) were cultured in the same media supplemented with 2 mM 
  Figure 2.       Lamin A is sumoylated at lysine 201 by SUMO-2, and E203G 
and E203K mutant lamin A proteins exhibit decreased sumoylation.   (A) The 
top shows the location of a match (MKEE) to the sumoylation site consensus 
sequence (    KXE) surrounding lysine 201 in the rod-containing domain of 
lamin A. In the bottom, extracts of HeLa cells transfected with GFP fusion 
constructs of wild-type lamin A or K201R mutant lamin A and HA-tagged 
SUMO-1 or -2 plasmids were subjected to immunoprecipitation using anti-
GFP antibodies followed by anti-HA Western blot. Western blots of the 
lysates using anti-GFP and anti-HA antibodies show levels of GFP  –  lamin A 
proteins and HA  –  SUMO-1/HA  –  SUMO-2 proteins (incorporated into major 
sumoylated proteins), respectively. (B) The top shows the location of the 
E203G and E203K mutations in lamin A associated with familial dilated 
cardiomyopathy at the conserved glutamic acid residue of the sumoylation 
site consensus sequence (    KXE) surrounding lysine 201. In the bottom, 
extracts of HeLa cells transfected with GFP fusion constructs of wild-type 
lamin A, E203G mutant lamin A, or E203K mutant lamin A along with 
HA-tagged SUMO-2 were subjected to immunoprecipitation with anti-GFP 
antibodies followed by anti-HA Western blot. Levels of transfected GFP  –
  lamin A proteins in the cell lysates were determined by Western blot using 
anti-GFP antibody.     JCB • VOLUME 182 • NUMBER 1 • 2008  38
sity of Kentucky, Lexington, KY) was used at 1:2,000, goat anti  –  SUMO-1 
antibody (Bethyl Laboratories, Inc.) was used at 1:1,000, rabbit anti  –
  SUMO-2 antibody (Abgent) was used at 1:500, and rabbit anti  –  lamin A 
antibody (Abcam) was used at 1:500. 
  Fluorescence and immunoﬂ  uorescence microscopy 
  Cells were seeded on coverslips. At 48 h after transfection with the wild-
type or point mutant GFP  –  lamin A expression constructs, HOECHST 33342 
and verapamil were added to the medium to ﬁ  nal concentrations of 5 and 
50   μ  g/ml, respectively. After incubation at 37  °  C for 30 min, the cover-
slips were washed twice with PBS and then incubated in 3.7% PFA at 
room temperature for 20 min. After two washes with PBS and a wash with 
distilled water, the coverslips were wicked on a kimwipe to partially dry 
and then mounted onto a slide spotted with 15   μ  l of VectorShield (Vector 
Laboratories). For immunostaining, after two washes with PBS, the cover-
slips were incubated in PBS containing 3% BSA at 37  °  C for 1 h and then 
incubated with rabbit anti  –  lamin A antibody (1:1,000) at 37  °  C for 30 min. 
After the coverslip was washed twice with PBS, it was incubated with Fluo-
rescein anti  –  rabbit IgG (1:200) at 37  °  C for 30 min. After two washes 
with PBS and a brief wash with distilled water, the coverslip was mounted 
onto a slide spotted with 15   μ  l of VectorShield. Excess ﬂ  uid was wicked 
from the coverslips, and the edges of the coverslip were sealed with ﬁ  nger-
nail polish. The ﬂ  uorescence was then visualized using a confocal (TCS 
SP5; Leica) or ﬂ  uorescent (Nikon) microscope with a Spotcam digital-
imaging camera (Nikon). Figures were made from the images using Photo-
shop (Adobe). 
  Trypan blue cell viability assay 
  Cells were collected by centrifugation at 1,000 rpm for 10 min at 4  °  C, and 
the pellet was washed twice with PBS. The cell pellet was then resuspended 
in PBS to a concentration of     10 
6   cells/ml. A one to one dilution of the 
suspension was prepared using a solution containing 0.4% trypan blue 
stain (Invitrogen), and the suspension was then loaded into the counting 
chamber of a hemacytometer. The number of stained cells, as well as the 
total number of cells, was counted, and the percentage of stained cells was 
taken to represent the percentage of cell death. Three datasets were ana-
lyzed for each experiment. 
  Statistical analysis 
  Statistical signiﬁ  cance was determined using Student  ’  s   t   test. A p-value of 
  <  0.05 was considered to be statistically signiﬁ  cant. 
region of the lamin A protein was cut out with EcoRI and BamHI diges-
tion and ligated into pEGFP-C2 vector (Clontech Laboratories, Inc.). 
Mutagenesis PCR was performed to generate GFP  –  lamin A K201R, 
E203G, and E203K mutants. The primers used for the mutagenesis were 
as follows (only top primers are listed, bottom primers are the reverse com-
plements of each of these): K201R, 5    -CTG CAG ACC ATG AGG GAG 
GAA CTG GAC-3    ; E203G, 5    -ACC ATG AAG GAG GGA CTG GAC 
TTC CAG-3    ; and E203K, 5    -ACC ATG AAG GAG AAA CTG GAC TTC 
CAG-3    . HA  –  SUMO-1 and   –  SUMO-2 were expressed using pcDNA3  –
  HA  –  SUMO-1 and   –  HA  –  SUMO-2 plasmids (provided by K. Orth, Univer-
sity of Texas Southwestern, Dallas, TX). 
  Immunoprecipitation analysis 
  For immunoprecipitation experiments, the cell pellets of the transfected 
HeLa cells or the human skin fibroblasts were resuspended in 500   μ  l 
RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.2% 
SDS, 0.25% sodium deoxycholate, and 1 mM EDTA) with protease in-
hibitor cocktail (Roche), 1 mM DTT, and 20 mM   N  -ethylmaleimide 
(added fresh). Cell lysis was performed by sonication, after which the 
sample was incubated on ice for 20 min. After centrifugation at 10,000 rpm 
at 4  °  C for 10 min, the supernatant was transferred to a fresh tube, and 
20   μ  l of the whole cell lysate was removed for analysis of the level of 
transfected GFP  –  lamin A. 300   μ  l of 50% protein G  –  Sepharose slurry 
(GE Healthcare) was washed three times with PBS and resuspended in 
RIPA buffer to make a 50% slurry. The cell lysate was precleared by 
mixing it with 150   μ  l of this slurry and 5   μ  g of goat IgG and incubating 
at 4  °  C for 60 min. After centrifugation at 4,000 rpm at 4  °  C for 1 min, 
the supernatant was transferred to a fresh tube and mixed with 5   μ  g of 
anti-GFP antibody (Bethyl Laboratories, Inc.) or anti  –  lamin A antibody 
(BD Biosciences). After incubation at 4  °  C for 60 min, 150   μ  l of 50% 
protein G  –  Sepharose slurry was added and incubated at 4  °  C for 60 min. 
The beads were washed with RIPA buffer four times and then boiled in 
50   μ  l of 4  ×   SDS-PAGE loading buffer. After brief centrifugation, the super-
natants were subjected to SDS-PAGE and Western blot using the antibodies 
described in the next section. 
  Western blot analysis and antibodies 
  SDS-PAGE and Western blot were performed according to standard proce-
dures. The antibodies and dilutions used to probe the Western blots were 
as follows. Goat anti-GFP antibody (Bethyl Laboratories, Inc.) was used at 
1:2,000, mouse anti-HA antibody (gift from D. Andres laboratory, Univer-
  Figure 3.       SUMO site K201R mutant lamin A and cardiomyopathy-associated E203G and E203K mutant lamin A proteins exhibit similar patterns of aber-
rant localization.   (A and B) Wild-type, K201R, E203G, and E203K lamin A GFP fusion expression plasmids were transfected into HeLa cells (A) or mouse 
embryonic cardiomyocytes (B), and the subcellular localization of the GFP  –  lamin A proteins was examined by confocal ﬂ  uorescence microscopy. DNA 
was visualized by staining with HOECHST 33342. Bars, 5   μ  m. (C) Wild-type, K201R, E203G, or E203K lamin A GFP fusion expression plasmids were 
transfected into HeLa cells, which were then analyzed by trypan blue assay to measure cell death. Data are shown as means   ±   SEM. (*, P   <   0.0001; **, 
P   <   0.0002; ***, P   <   0.0001 [for lamin A mutants vs. wild type]) and are each from three datasets.     39 SUMOYLATION OF LAMIN A   • Zhang and Sarge 
  Online supplemental material 
  Table S1 contains quantitation analysis for the experiments in   Fig. 3 (A and B) 
and Fig. 4 B  . This table shows the percentages of HeLa cells or cardio-
myocytes transfected with GFP lamin A wild-type, K201R, E203G, or E203K 
mutants that exhibit abnormal lamin A localization and the percentages of 
normal versus E203K lamin A ﬁ  broblasts showing abnormal lamin A localiza-
tion/nuclear morphology. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200712124/DC1. 
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2+  -free digestion 
buffer containing 0.5 mg/ml collagenase (type II; Worthington) and 1 mg/ml 
pancreatin for two 15-min cycles. Digested tissue yielded a large fraction 
of single spontaneously beating cells in culture media consisting of DME 
containing 10% FBS. 
  Figure 4.       Fibroblasts from an individual with E203K lamin A mutation 
exhibit decreased lamin A sumoylation, altered lamin A localization/
nuclear morphology, and increased cell death.   (A) Extracts prepared from 
skin ﬁ   broblasts of a normal individual and individual heterozygous for 
the E203K lamin A mutation were subjected to immunoprecipitation using 
anti  –  lamin A antibodies followed by Western blot assay using anti  –  SUMO-2 
antibodies or anti  –  lamin A antibodies (different from those used for 
immunoprecipitation). (B) Skin ﬁ  broblasts of a normal individual and the 
individual heterozygous for the E203K lamin A mutation were subjected 
to immunoﬂ  uorescence analysis using anti  –  lamin A antibodies. DNA was 
visualized by staining with HOECHST 33342. Bar, 5   μ  m. (C) Skin ﬁ  bro-
blasts of a normal individual and E203K lamin A individual were analyzed 
by trypan blue assay to measure cell death. Data are shown as means   ±   
SEM (P   <   0.0038 for E203K lamin A mutant cells vs. wild-type cells) and 
are from three datasets.     